Skip to main content

Apotex, Inc. v. Sebelius

Certiorari Denied

Petition for certiorari denied on January 18, 2011.

Docket No.10-453

Issue

Whether a generic drug manufacturer may forfeit marketing exclusivity under 21 U.S.C. § 355(j)(5)(D) based on “unilateral”? action by the holder of the challenged patent.

Welcome to SCOTUSblog

Tell us a bit about yourself so we can tailor what you see. You can update these any time in your account.